Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +1.21% to 10479.39, DAX (0.53%) to 24856.15, CAC40 (0.18%) to 8313.24, STOXX 600 +0.10% to 621.60

Feb 11 ,2026

  • Synopsis:

    • European equity markets finished mostly mixed. FTSE 100 the big outperformer. DAX lags. Heavy earnings calendar influencing. Energy names, miners and utilities stocks outperform; media, travel/leiusure, financials and tech under pressure. Follows mostly weaker performance on Tuesday.

    • AI disruption fears back in focus with wealth management and brokerage firms latest group hit by AI disruption/competition concerns after Altruist released tax and financial planning tool. Selloff mirrors one that hit software names last week in wake of Anthropic's Claude Cowork plugin announcements.

    • In latest geopolitacal developments, The FT reports Ukraine plans elections and a peace referendum with Russia under U.S. pressure to meet a 15-May deadline. In UK, PM Starmer reaffirmed his leadership on Tuesday after cabinet backing, amid criticism over policies and Mandelson appointment.

    • Macro-data light with just Italy December Industrial Production (0.4%) m/m vs consensus (0.5%) and prior +1.5%.

    • On a busy earning calendar, early focus on energy companies as Siemens Energy (ENR.GR), Aker BP (AKRBP.NO) and TotalEnergies (TTE.FP) all reported Q4 earnings. In the financial sector, ABN AMRO Bank (ABN.NA) and and Commerzbank (CBK.GR) issued Q4 earnings numbers. Amongst Food and Beverages groups, Heineken (HEIA.NA) reported FY earnings , whilst Mowi (MOWI.NO) and Koninklijke Ahold Delhaize (AD.NA) issued Q4 earnings. Focus on Industrials with SGS (SGSN.SW), Schindler Holding (SCHN.SW), and Randstad (RAND.NA) reporting end of year numbers. In HealthCare, Gerresheimer (GXI.GR) is trading sharply lower on the back of the group deferring publication of its FY25 financial statements due to an ongoing investigation initiated by the company, leading to an expected non-cash impairment of ~€220-240M in FY25 and initiation of the sale of its US subsidiary Centor to optimise capital and financing structure this year

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, UK Q4 preliminary GDP, Jan house price balance - RICS, monthly GDP tracker - NIESR, Dec trade balance, industrial/manufacturing production and construction output.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Oil & Gas +3.78%, Basic Resources +3.02%, Utilities +2.14%, Telecom +1.44%, Real Estate +0.77%, Health Care +0.51%, Food & Beverage +0.48%, Autos & Parts +0.30%, Construct & Mtls +0.20%

      • Underperformers:

        • Media (2.59%), Travel & Leisure (2.36%), Financial Svcs (2.03%), Technology (1.79%), Banks (1.05%), Insurance (1.00%), Retail (0.39%), Chemicals (0.25%), Ind Goods & Svcs (0.08%), Persnl & HHold Goods (0.05%)

    • Macro:

      • Central banks:

        • Lagarde lays out key reforms needed to boost EU resilience, source says -- Reuters

        • Crypto's crash utterly undermines George Osborne's call for a payments revolution -- Telegraph

      • EU:

        • The rise of 'Merzoni': How an alliance between Germany's and Italy's leaders is reshaping Europe -- TheConversation

        • France set to clash with Germany and Italy as EU leaders seek economic boost -- euronews

        • Italy aligns with Germany by cooling on Macron's joint EU debt plan -- Politico

      • UK:

        • UK economy set to have recorded modest growth amid budget concerns -- TheIndependent

        • Rebuilding EU ties 'the biggest prize' for British economy, Reeves says -- Politico

        • OBR under fire for secrecy over economic forecasts -- Telegraph

        • UK first-time buyers too pessimistic about securing a property, study says -- FT

      • Germany:

        • Germany's Gas Refill Season Looks Tough, Market Manager Says -- Bloomberg

      • France:

        • Macron's golden chance to shield France's Central Bank-- Bloomberg

        • Macron's failed bet to achieve full employment by 2027 -- LeMonde

      • Italy:

        • Italy industry output falls in December, but signs long slump is easing -- Reuters

    • Company news:

      • Notable Gainers

        • +57.6% CTM.SS (Catena Media SEK2.99, +1.11) -- FY earnings

        • +25.7% IGR.LN (IG Design Group £0.61, +0.12) -- 9M trading update

        • +16.2% FIA1S.FH (Finnair €3.57, +0.50) -- Q4 earnings

        • +11.6% AD.NA (Koninklijke Ahold Delhaize €38.73, +4.01) -- Q4 earnings

        • +9.8% VBK.GR (Verbio €25.00, +2.28) -- Deutsche Bank upgrade

        • +7.7% PZC.LN (PZ Cussons £0.88, +0.06) -- H1 earnings; CMD update

        • +6.5% WCH.GR (Wacker Chemie €82.40, +5.15) -- Berenberg upgrade

        • +5.8% ALVU.FP (Vente-Unique.com €16.35, +0.90) -- Q1 revenue

        • +5.5% BME.LN (B&M European Value Retail £1.81, +0.10) -- Peel Hunt upgrade

        • +5.0% RSW.LN (Renishaw £40.90, +1.95) -- H1 earnings

        • +4.8% HNSA.SS (Hansa Biopharma SEK38.90, +1.76) -- Q4 earnings

        • +4.7% MT.NA (ArcelorMittal €55.32, +2.48) -- Jefferries upgrade

        • +4.4% HEIA.NA (Heineken €77.90, +3.28) -- FY earnings

        • +4.3% PAF.LN (Pan African Resources $1.43, +0.06) -- 6M trading update

        • +4.1% HEIO.NA (Heineken €70.00, +2.75) -- FY earnings

        • +3.6% BG.AV (BAWAG Group €137.20, +4.80) -- FY earnings

        • +3.2% STB.NO (Storebrand NOK180.20, +5.60) -- Q4 earnings

        • +2.8% SRV1V.FH (SRV Group €5.16, +0.14) -- Q4 earnings

        • +1.8% ENTRA.NO (Entra ASA NOK115.80, +2.00) -- Q4 earnings

        • +1.5% RWS.LN (RWS Holdings £0.82, +0.01) -- trading update

      • Notable Decliners

        • -31.4% GXI.GR (Gerresheimer €18.98, -8.53) -- defers FY results publication; initiates sale of Centor

        • -26.3% RENX.LN (Renalytix £0.04, -0.01) -- H1 trading update

        • -20.8% DSY.FP (Dassault Systemes €18.03, -4.67) -- Q4 earnings

        • -14.7% KAR.SS (Karnov Group SEK64.90, -11.20) -- Q4 earnings

        • -13.4% STJ.LN (St. James's Place £12.51, -1.94) -- Altruist's launch of a tax-planning tool

        • -12.3% IOM.LN (iomart Group £0.17, -0.02) -- CFO steps down

        • -11.6% VP.LN (Vp Plc £4.75, -0.64) -- 10M trading update

        • -10.6% RAND.NA (Randstad €27.48, -3.24) -- Q4 earnings

        • -10.3% SCHP.SW (Schindler Holding CHF283.80, -32.20) -- Q4 earnings

        • -10.0% GCM.LN (GCM Resources £0.09, -0.01) -- places 15.2M new ordinary shares at 8.2p/share to raise ~£1.25M

        • -9.9% GLE.LN (MJ Gleeson £3.60, -0.39) -- H1 earnings

        • -9.8% ASY.FP (Assystem €44.60, -4.70) -- FY revenue

        • -9.3% BFF.IM (BFF Bank SpA €4.45, -0.44) -- FY earnings

        • -8.6% NORBT.NO (Norbit NOK187.00, -17.60) -- Q4 earnings

        • -8.3% NETI.B.SS (Net Insight SEK1.95, -0.17) -- Q4 earnings

        • -8.1% REG1V.FH (Revenio Group €18.28, -1.58) -- Q4 earnings

        • -7.6% BGN.IM (Banca Generali €53.90, -4.40) -- Q4 earnings

        • -7.1% ANORA.FH (Anora Group €4.14, -0.32) -- Q4 earnings

        • -7.1% BOUL.SS (Boule Diagnostics SEK4.47, -0.35) -- Q4 earnings

        • -5.8% SANOMA.FH (Sanoma €9.08, -0.55) -- Q4 earnings

        • -5.7% AMS.SW (ams-OSRAM CHF8.04, -0.49) -- Deutsche Bank downgrade

        • -5.6% MIPS.SS (MIPS SEK283.20, -16.80) -- Q4 earnings

        • -5.3% EOLU.B.SS (Eolus Aktiebolag SEK34.75, -1.95) -- Q4 earnings

        • -5.3% NOBI.SS (Nobia SEK3.66, -0.21) -- SEK1.5B rights issue at SEK 1.78/share

        • -5.2% QLT.LN (Quilter £1.79, -0.10) -- Altruist's launch of a tax-planning tool

        • -5.2% ERA.FP (Eramet €60.30, -3.30) -- JV PT Weda Bay Nickel update

        • -5.1% MUM.GR (Mensch & Maschine Software €40.55, -2.20) -- prelim. FY earnings

        • -4.8% SEE.LN (Seeing Machines £0.04, -0.00) -- Q4 earnings

        • -4.4% QTX.LN (Quartix Technologies £2.83, -0.13) -- updates on FRC Review

        • -4.1% 2020.NO (2020 Bulkers NOK136.00, -5.80) -- Q4 earnings

        • -3.8% SGSN.SW (SGS CHF93.94, -3.72) -- FY earnings

        • -3.4% ATEA.NO (Atea NOK140.80, -5.00) -- Handelsbanken dwongrade

        • -3.1% IMMU.SS (Mendus SEK4.64, -0.15) -- FY earnings

        • -2.9% GFC.FP (Gecina €78.65, -2.30) -- FY earnings

        • -2.7% NOHO.FH (NoHo Partners €7.90, -0.22) -- Q4 earnings

        • -2.4% G.IM (Assicurazioni Generali €34.56, -0.86) -- acquires Swiss Life Network

        • -2.1% WIHL.SS (Wihlborgs Fastigheter SEK92.15, -2.00) -- ABG Sundal Collier downgrade; Pareto downgrade

        • -2.0% RAIVV.FH (Raisio €2.76, -0.06) -- Q4 earnings

        • -2.0% CBK.GR (Commerzbank €33.82, -0.71) -- Q4 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: DO & CO (DOC.AV)

        • Benelux: Anheuser-Busch InBev (ABI.BB), Fagron (FAGR.BB), KBC Group (KBC.BB), Sipef (SIP.BB), Ontex Group (ONTEX.BB), Adyen (ADYEN.NA), NN Group (NN.NA), DSM-Firmenich (DSFIR.NA), Flow Traders (FLOW.NA)

        • Finland: Metso Corp. (METSO.FH), Orion (ORNBV.FH), Mandatum (MANTA.FH), Kemira (KEMIRA.FH), Hiab (HIAB.FH), Outokumpu (OUT1V.FH), Tietoevry (TIETO.FH), Vaisala (VAIAS.FH), Harvia (HARVIA.FH), Marimekko (MEKKO.FH), Oma Savings Bank (OMASP.FH), Capman (CAPMAN.FH), Pihlajalinna (PIHLIS.FH), Atria (ATRAV.FH), Etteplan (ETTE.FH), Verkkokauppa.com (VERK.FH)

        • France: Hermes (RMS.FP), L'Oreal (OR.FP), Legrand (LR.FP), Unibail-Rodamco-Westfield (URW.FP), Ipsen (IPN.FP), TF1 (TFI.FP)

        • Germany: Siemens (SIE.GR), Mercedes-Benz Group (MBG.GR), Deutsche Börse (DB1.GR), thyssenKrupp (TKA.GR), KWS SAAT (KWS.GR), Carl Zeiss Meditec (AFX.GR), Verbio (VBK.GR), CANCOM (COK.GR)

        • Norway: Orkla (ORK.NO), AutoStore Holdings (AUTO.NO), SpareBank 1 SMN (MING.NO), Veidekke (VEI.NO), TGS-NOPEC Geophysical Co. (TGS.NO), Kitron (KIT.NO), SpareBank 1 Nord-Norge (NONG.NO), Norconsult (NORCO.NO), Aker BioMarine (AKBM.NO), LINK Mobility Group Holding (LINK.NO), Pexip Holding (PEXIP.NO), B2 Impact (B2I.NO), Elmera Group (ELMRA.NO), Solstad Offshore (SOFF.NO), Sea1 Offshore (SEA1.NO), Akastor (AKAST.NO), Axactor (ACR.NO), Komplett (KOMPL.NO), Hexagon Composites (HEX.NO), Nekkar (NKR.NO), ArcticZymes Technologies (AZT.NO), Lumi Gruppen (LUMI.NO), Vistin Pharma (VISTN.NO), Webstep (WSTEP.NO), REC Silicon (RECSI.NO), Electromagnetic Geoservices (EMGS.NO)

        • Other: Íslandsbanki (ISB.IR)

        • Southern Europe: MAPFRE (MAP.SM), Iveco Group (IVG.IM), Elica (ELC.IM)

        • Sweden: Verisure (VSURE.SS), NIBE Industrier (NIBE.B.SS), Camurus (CAMX.SS), Hufvudstaden (HUFV.A.SS), AQ Group (AQ.SS), Lindab International (LIAB.SS), Vimian Group (VIMIAN.SS), INVISIO (IVSO.SS), BioGaia (BIOG.B.SS), Ambea (AMBEA.SS), Embracer Group (EMBRAC.B.SS), Fastpartner (FPAR.A.SS), Volati (VOLO.SS), Instalco (INSTAL.SS), RaySearch Laboratories (RAY.B.SS), Yubico (YUBICO.SS), Nederman Holding (NMAN.SS), MEKO (MEKO.SS), Swedencare (SECARE.SS), Lime Technologies (LIME.SS), Devyser Diagnostics (DVYSR.SS), Genovis (GENO.SS), C-RAD (CRAD.B.SS), Sedana Medical (SEDANA.SS), Nordisk Bergteknik (NORB.B.SS), ProfilGruppen (PROF.B.SS), Ferronordic (FNM.SS), Nilörngruppen (NIL.B.SS), Tradedoubler (TRAD.SS), Precise Biometrics (PREC.SS), Active Biotech (ACTI.SS), Vivesto (VIVE.SS), Alligator Bioscience (ATORX.SS)

        • Switzerland: Swisscom (SCMN.SW), Banque Cantonale Vaudoise (BCVN.SW), Dätwyler Holding (DAE.SW), Bell Food Group (BELL.SW), Glarner Kantonalbank (GLKBN.SW), Leonteq (LEON.SW), Bachem (BANB.SW)

        • UK: British American Tobacco (BATS.LN), RELX (REL.LN), Schroders (SLN), Ashmore Group (ASHM.LN), Carasent (0H9M.LN), Unilever (ULVR.LN)

      • Trading Updates:

        • Benelux: CVC Capital Partners (CVC.NA)

        • DACHs: STRABAG (STR.AV)

        • France: Ubisoft Entertainment (UBI.FP)

  • Data:

    • Economics:

      • Italy Dec Industrial Production +3.2% y/y vs consensus +1.2% and prior +1.4%

    • Markets:

      • WTI Crude (26-Mar): +$1.24 or +1.94% to $65.20

      • €-$ (0.0017) or (0.14%) to 1.1878

      • £-$ +0.0011 or +0.08% to 1.3654

      • €-£ (0.0019) to 0.8701

      • S&P 500 +0.12%

      • Performance year-to-date:

        • FTSE 100: +5.44%

        • DAX: +1.49%

        • CAC: +2.01%

        • MIB: +3.48%

        • Stoxx 600: +4.96%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE